标题:Early-stage predictors for treatment responses in patients with active lupus nephritis
作者:Liu, G.; Wang, H.; Le, J.; Lan, L.; Xu, Y.; Yang, Y.; Chen, J.; Han, F.
作者机构:[Liu, G.; Wang, H.; Le, J.; Lan, L.; Xu, Y.; Yang, Y.; Chen, J.; Han, F.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou, Zhejia 更多
通讯作者:Han, F
通讯作者地址:[Han, F]First Affiliated Hosp, Kidney Dis Ctr, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.
来源:LUPUS
出版年:2019
卷:28
期:3
页码:283-289
DOI:10.1177/0961203319826703
关键词:Complement; immunosuppressive therapy; lupus nephritis; remission; serum; albumin; urine protein-to-creatinine ratio
摘要:Objective We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission.; Methods Sixty-four LN patients who were diagnosed with class III, IV, V or V+III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating characteristic curves were used to test the predictive values of urinary protein-to-creatinine ratio (UPCR), serum albumin and complement C3 at the first, second and third months as predictors for remission at the sixth month.; Results The patients' renal pathologies were class III (five cases), class IV (33 cases), class V (nine cases) and class V+III/IV (17 cases). All patients received standard immunosuppressive therapy. Forty-six (71.9%) patients (grouped as the remission group) achieved remission at the end of the sixth month, including 23 complete remissions and 23 partial remissions. The other 18 patients were grouped as the no-remission group. There were no significant differences in clinical data, proportion of immunosuppressive therapy or renal pathological characteristics between the remission group and no-remission group at baseline, except the serum urea nitrogen of the remission group was lower than in the no-remission group. The UPCR were significantly lower in the remission group than in the no-remission group at months 1, 2, 3 and 6, respectively, while the serum albumin was significantly higher in the remission group than in the no-remission group at months 3 and 6, respectively. There were no significant differences in serum creatinine between the remission group and no-remission group, except at month 1. The C3 levels were higher in the remission group than in the no-remission group at months 1, 2 and 3, respectively. The areas under the curve (AUC) of the change percentage of UPCR at month 3 and the serum albumin at month 3 were the most significant (AUC 0.778, p=0.002; AUC 0.773, p=0.001, respectively). The cutoff value of the change percentage of UPCR at month 3 was 59%. The cutoff value of serum albumin at month 3 was 32.9g/l.; Conclusion The change percentage of UPCR 59% and the serum albumin 32.9g/l at the third month were valuable for predicting remission at the sixth month in LN. Because of the small-size and retrospective nature, this study needs to be validated.
收录类别:SCOPUS;SCIE
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061042345&doi=10.1177%2f0961203319826703&partnerID=40&md5=c091ccc08e31fc4105ae6b6a44d40a44
TOP